Empagliflozin is a novel sodium glucose co-transporter-2 (SGLT-2) inhibitor, which is useful for improving glycaemic control in adults with type-2 diabetes mellitus.
The designation recognizes Seeq's expertise in enabling faster insights and better business outcomes for life sciences customers, including Bristol Myers Squibb, with advanced analytics innovations.
The investment will enable the company to enter European markets as well as enhance margins in current markets
Sanjeev is currently the Country President for AstraZeneca Malaysia
Implants from the U.S. startup Allay Therapeutics are designed to relieve pain after knee surgery for up to three weeks
The current ruling will assure the safety of the use of Ranitidine for Indian patients
Results are the first demonstration of efficacy for an investigational mRNA cancer treatment in a randomized clinical trial
The yoga protocol included gentle and restorative yoga postures(asana) with regular periods of relaxation and pranayama
They also released the Operational Guidelines for Wellness activities at AB-HWCs
This one-of-a-kind ophthalmic subspecialty division is focused on the treatment of the eye condition glaucoma
Subscribe To Our Newsletter & Stay Updated
